unknown
Stage
About
Brazosneuro offers a proprietary Neural-Injury Assessment Test that uses blood biomarkers and genetic markers to objectively diagnose mild to moderate traumatic brain injury in the post-acute or chronic phase.
Explore Brazosneuro's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.